119 related articles for article (PubMed ID: 31075759)
21. Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects.
Szinnai G; Morgenthaler NG; Berneis K; Struck J; Müller B; Keller U; Christ-Crain M
J Clin Endocrinol Metab; 2007 Oct; 92(10):3973-8. PubMed ID: 17635944
[TBL] [Abstract][Full Text] [Related]
22. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism.
Beshyah SA; Thomas E; Kyd P; Sharp P; Fairney A; Johnston DG
Clin Endocrinol (Oxf); 1994 Mar; 40(3):383-91. PubMed ID: 8187303
[TBL] [Abstract][Full Text] [Related]
23. Effects of interrupting the renin-angiotensin system on sodium excretion in man.
Brown J
J Physiol; 1988 Jan; 395():17-40. PubMed ID: 3045295
[TBL] [Abstract][Full Text] [Related]
24. The effect of growth hormone (GH) replacement therapy on sympathetic nerve hyperactivity in hypopituitary adults: a double-blind, placebo-controlled, crossover, short-term trial followed by long-term open GH replacement in hypopituitary adults.
Sverrisdóttir YB; Elam M; Caidahl K; Söderling AS; Herlitz H; Johannsson G
J Hypertens; 2003 Oct; 21(10):1905-14. PubMed ID: 14508197
[TBL] [Abstract][Full Text] [Related]
25. Growth hormone replacement inhibits renal and hepatic 11 beta-hydroxysteroid dehydrogenases in ACTH-deficient patients.
Walker BR; Andrew R; MacLeod KM; Padfield PL
Clin Endocrinol (Oxf); 1998 Aug; 49(2):257-63. PubMed ID: 9828916
[TBL] [Abstract][Full Text] [Related]
26. Low-dose ghrelin infusion--evidence against a hormonal role in food intake.
Lippl F; Erdmann J; Steiger A; Lichter N; Czogalla-Peter C; Bidlingmaier M; Tholl S; Schusdziarra V
Regul Pept; 2012 Feb; 174(1-3):26-31. PubMed ID: 22120829
[TBL] [Abstract][Full Text] [Related]
27. The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults.
Weaver JU; Thaventhiran L; Noonan K; Burrin JM; Taylor NF; Norman MR; Monson JP
Clin Endocrinol (Oxf); 1994 Nov; 41(5):639-48. PubMed ID: 7828353
[TBL] [Abstract][Full Text] [Related]
28. Osmoregulation of thirst and vasopressin secretion in insulin-dependent diabetes mellitus.
Thompson CJ; Davis SN; Butler PC; Charlton JA; Baylis PH
Clin Sci (Lond); 1988 Jun; 74(6):599-606. PubMed ID: 3396297
[TBL] [Abstract][Full Text] [Related]
29. Estro-progestin supplementation enhances the growth hormone secretory responsiveness to ghrelin infusion in postmenopausal women.
Villa P; Costantini B; Perri C; Suriano R; Ricciardi L; Lanzone A
Fertil Steril; 2008 Feb; 89(2):398-403. PubMed ID: 17509580
[TBL] [Abstract][Full Text] [Related]
30. Osmotic and non-osmotic regulation of thirst and vasopressin secretion in patients with compulsive water drinking.
Thompson CJ; Edwards CR; Baylis PH
Clin Endocrinol (Oxf); 1991 Sep; 35(3):221-8. PubMed ID: 1742879
[TBL] [Abstract][Full Text] [Related]
31. Endothelin induces diuresis and natriuresis in the rat by acting on proximal tubular cells through a mechanism mediated by lipoxygenase products.
Perico N; Cornejo RP; Benigni A; Malanchini B; Ladny JR; Remuzzi G
J Am Soc Nephrol; 1991 Jul; 2(1):57-69. PubMed ID: 1655094
[TBL] [Abstract][Full Text] [Related]
32. Effect of hyperosmotic solutions on salt excretion and thirst in rats.
Schoorlemmer GH; Johnson AK; Thunhorst RL
Am J Physiol Regul Integr Comp Physiol; 2000 Apr; 278(4):R917-23. PubMed ID: 10749779
[TBL] [Abstract][Full Text] [Related]
33. The effect of drinking on atrial natriuretic peptide, vasopressin and thirst appreciation in hyperosmolar man.
Burrell LM; Lambert HJ; Baylis PH
Clin Endocrinol (Oxf); 1991 Sep; 35(3):229-34. PubMed ID: 1835911
[TBL] [Abstract][Full Text] [Related]
34. Metabolic and endocrine effects of physiological increments in plasma ghrelin concentrations.
Lucidi P; Murdolo G; Di Loreto C; Parlanti N; De Cicco A; Fatone C; Taglioni C; Fanelli C; Broglio F; Ghigo E; Bolli GB; Santeusanio F; De Feo P
Nutr Metab Cardiovasc Dis; 2005 Dec; 15(6):410-7. PubMed ID: 16314227
[TBL] [Abstract][Full Text] [Related]
35. Increased thirst and plasma arginine vasopressin levels during 2-deoxy-D-glucose-induced glucoprivation in humans.
Thompson DA; Campbell RG; Lilavivat U; Welle SL; Robertson GL
J Clin Invest; 1981 Apr; 67(4):1083-93. PubMed ID: 7204569
[TBL] [Abstract][Full Text] [Related]
36. Osmoregulation of vasopressin and thirst: comparison of 20% mannitol with 5% saline as osmotic stimulants in healthy man.
Phillips EM; Butler T; Baylis PH
Clin Endocrinol (Oxf); 1994 Aug; 41(2):207-12. PubMed ID: 7923825
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular effects of growth hormone replacement therapy in hypopituitary adults.
Beshyah SA; Shahi M; Skinner E; Sharp P; Foale R; Johnston DG
Eur J Endocrinol; 1994 May; 130(5):451-8. PubMed ID: 8180671
[TBL] [Abstract][Full Text] [Related]
38. The osmotic thresholds for thirst and vasopressin release are similar in healthy man.
Thompson CJ; Bland J; Burd J; Baylis PH
Clin Sci (Lond); 1986 Dec; 71(6):651-6. PubMed ID: 3791867
[TBL] [Abstract][Full Text] [Related]
39. Disturbance of osmoregulated thirst and vasopressin secretion in thyrotoxicosis.
Harvey JN; Nagi DK; Baylis PH; Wilkinson R; Belchetz PE
Clin Endocrinol (Oxf); 1991 Jul; 35(1):29-33. PubMed ID: 1889137
[TBL] [Abstract][Full Text] [Related]
40. Taurine-induced diuresis and natriuresis in cirrhotic patients with ascites.
Gentile S; Bologna E; Terracina D; Angelico M
Life Sci; 1994; 54(21):1585-93. PubMed ID: 8196477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
